BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 15897302)

  • 1. Pulmonary arterial hypertension in systemic sclerosis: diagnostic pathway and therapeutic approach.
    Robertson L; Pignone A; Kowal-Bielecka O; Fiori G; Denton CP; Matucci-Cerinic M
    Ann Rheum Dis; 2005 Jun; 64(6):804-7. PubMed ID: 15897302
    [No Abstract]   [Full Text] [Related]  

  • 2. Assessment and management of scleroderma lung disease.
    Bolster MB; Silver RM
    Curr Opin Rheumatol; 1999 Nov; 11(6):508-13. PubMed ID: 10551676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dyspnea due to pulmonary hypertension and interstitial lung disease in scleroderma: room for improvement in diagnosis and management.
    Racz H; Mehta S
    J Rheumatol; 2006 Sep; 33(9):1723-5. PubMed ID: 16960934
    [No Abstract]   [Full Text] [Related]  

  • 4. Desquamative interstitial pneumonia as the initial manifestation of systemic sclerosis.
    Swartz JS; Chatterjee S; Parambil JG
    J Clin Rheumatol; 2010 Sep; 16(6):284-6. PubMed ID: 20808169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening and therapy of pulmonary hypertension in systemic sclerosis.
    Bull TM
    Curr Opin Rheumatol; 2007 Nov; 19(6):598-603. PubMed ID: 17917541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Latent pulmonary inflammation in patients with systemic sclerosis.
    Sánchez-Vidaurre S; Simeón CP; Cruz MJ; Fonollosa V; Vilardell M; Morell F; Muñoz X
    Arch Bronconeumol; 2012 Jan; 48(1):8-13. PubMed ID: 22133713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary arterial hypertension in systemic sclerosis: can we predict responders for successful therapy?
    Sasahara AA
    J Rheumatol; 2009 Apr; 36(4):665-6. PubMed ID: 19342719
    [No Abstract]   [Full Text] [Related]  

  • 8. Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma.
    Garin MC; Highland KB; Silver RM; Strange C
    J Rheumatol; 2009 Feb; 36(2):330-6. PubMed ID: 19208563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring and Diagnostic Approaches for Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis.
    Valenzuela A; Nandagopal S; Steen VD; Chung L
    Rheum Dis Clin North Am; 2015 Aug; 41(3):489-506. PubMed ID: 26210131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Key features in the management of diffuse interstitial pulmonary disease].
    Fernández DI; Sánchez RP; Moreno AF; Fernández Fabrellas E
    Arch Bronconeumol; 2009; 45 Suppl 3():3-8. PubMed ID: 20116737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interstitial lung disease (ILD) in systemic sclerosis (SSc)].
    Novak S
    Reumatizam; 2010; 57(2):105-8. PubMed ID: 21875013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pulmonary arterial hypertension and generalized scleroderma. A propos of 10 cases].
    Commeau P; Grollier G; Foucaúlt JP; Potier JC
    Poumon Coeur; 1983; 39(1):31-5. PubMed ID: 6866890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advancements in diagnosis of pulmonary arterial hypertension in scleroderma.
    Steen V
    Arthritis Rheum; 2005 Dec; 52(12):3698-700. PubMed ID: 16320319
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pulmonary arterial hypertension in collagen disease: experiences of the German Network for Systemic Scleroderma].
    Hunzelmann N; Riemekasten G
    Dtsch Med Wochenschr; 2006 Dec; 131(49 Suppl 9):S325-7. PubMed ID: 17139598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practical approach to screening for scleroderma-associated pulmonary arterial hypertension.
    Fischer A; Bull TM; Steen VD
    Arthritis Care Res (Hoboken); 2012 Mar; 64(3):303-10. PubMed ID: 22076819
    [No Abstract]   [Full Text] [Related]  

  • 16. Pulmonary hypertension in interstitial lung disease.
    Polomis D; Runo JR; Meyer KC
    Curr Opin Pulm Med; 2008 Sep; 14(5):462-9. PubMed ID: 18664977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The occurrence of pulmonary hypertension in patients with systemic sclerosis hospitalized in the Department of Rheumatology and Internal Diseases Medical University of Białystok in years 2003-2004.
    Gińdzieńska-Sieśkiewicz E; Kowal-Bielecka O; Kita J; Lisowska A; Domysławska I; Musiał W; Sierakowski S
    Rocz Akad Med Bialymst; 2005; 50 Suppl 1():297-300. PubMed ID: 16119691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pulmonary arterial hypertension as symptom of a limited form of systemic sclerosis in a nonagenerian].
    Fernández Ibáñez JM; Morales Ballesteros C; Carrasco Fernández JA; Perez Alonso L
    Rev Esp Geriatr Gerontol; 2010; 45(6):361-2. PubMed ID: 20678826
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pulmonary hypertension in patients with systemic sclerosis].
    Ciurzyński M; Bienias P; Pruszczyk P
    Kardiol Pol; 2007 Aug; 65(8):994-1000. PubMed ID: 17853323
    [No Abstract]   [Full Text] [Related]  

  • 20. Palliation of systemic sclerosis-associated pulmonary hypertension by atrial septostomy.
    Allcock RJ; O'Sullivan JJ; Corris PA
    Arthritis Rheum; 2001 Jul; 44(7):1660-2. PubMed ID: 11465717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.